Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fluorine-18 is a radioactive isotope of fluorine and the most widely utilized positron emitter in clinical Positron Emission Tomography (PET) imaging (StatPearls). It possesses a physical half-life of approximately 109.7 minutes, which is long enough to allow for complex multi-step radiochemical syntheses and transport to imaging centers, yet short enough to limit the radiation dose to the patient (PubChem). Fluorine-18 is not a therapeutic target; rather, it is a diagnostic radionuclide that is covalently bonded to various targeting ligands or metabolic substrates to create radiopharmaceuticals (NIH). The most prominent example is Fludeoxyglucose (18F), used to visualize glucose metabolism in oncology, neurology, and cardiology (NCI). When the isotope decays, it emits a positron that annihilates with an electron, producing gamma rays that allow for the precise localization of the tracer within the body, facilitating the diagnosis and monitoring of diseases such as cancer and Alzheimer's (Wikipedia).
Fluorine-18 decays via positron emission (beta plus decay), where a proton is converted into a neutron, emitting a positron and a neutrino (Wikipedia). The emitted positron subsequently undergoes annihilation with a nearby electron, producing two 511 keV gamma photons emitted approximately 180 degrees apart, which are detected by Positron Emission Tomography (PET) scanners to reconstruct three-dimensional images of tracer distribution (StatPearls).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fluorine-18 (18F) (18F).